Valeo Financial Advisors’s BioCryst Pharmaceuticals BCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-27,000
| Closed | -$286K | – | 488 |
|
|
2022
Q2 | $286K | Sell |
27,000
-500
| -2% | -$5.3K | 0.02% | 356 |
|
|
2022
Q1 | $447K | Sell |
27,500
-324
| -1% | -$5.27K | 0.02% | 332 |
|
|
2021
Q4 | $385K | Sell |
27,824
-500
| -2% | -$6.92K | 0.02% | 349 |
|
|
2021
Q3 | $407K | Hold |
28,324
| – | – | 0.02% | 331 |
|
|
2021
Q2 | $448K | Sell |
28,324
-500
| -2% | -$7.91K | 0.03% | 266 |
|
|
2021
Q1 | $293K | Sell |
28,824
-8,376
| -23% | -$85.1K | 0.01% | 353 |
|
|
2020
Q4 | $277K | Buy |
37,200
+17,500
| +89% | +$130K | 0.01% | 346 |
|
|
2020
Q3 | $68K | Buy |
19,700
+15,500
| +369% | +$53.5K | 0.01% | 548 |
|
|
2020
Q2 | $20K | Buy |
+4,200
| New | +$20K | ﹤0.01% | 995 |
|